DK1539964T3 - Cellectin-komplementaktiverende proteinkimærer - Google Patents

Cellectin-komplementaktiverende proteinkimærer

Info

Publication number
DK1539964T3
DK1539964T3 DK03794818T DK03794818T DK1539964T3 DK 1539964 T3 DK1539964 T3 DK 1539964T3 DK 03794818 T DK03794818 T DK 03794818T DK 03794818 T DK03794818 T DK 03794818T DK 1539964 T3 DK1539964 T3 DK 1539964T3
Authority
DK
Denmark
Prior art keywords
fusion protein
complement
activating
activating protein
cellectin
Prior art date
Application number
DK03794818T
Other languages
Danish (da)
English (en)
Inventor
Leif Kongerslev
Dietmar Weilguny
Finn Matthiesen
Original Assignee
Natimmune As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natimmune As filed Critical Natimmune As
Application granted granted Critical
Publication of DK1539964T3 publication Critical patent/DK1539964T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK03794818T 2002-09-10 2003-09-10 Cellectin-komplementaktiverende proteinkimærer DK1539964T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200201328 2002-09-10
PCT/DK2003/000585 WO2004024925A2 (en) 2002-09-10 2003-09-10 Collectin-complement activating protein chimeras

Publications (1)

Publication Number Publication Date
DK1539964T3 true DK1539964T3 (da) 2007-05-07

Family

ID=31984965

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03794818T DK1539964T3 (da) 2002-09-10 2003-09-10 Cellectin-komplementaktiverende proteinkimærer

Country Status (11)

Country Link
US (1) US20060188963A1 (de)
EP (1) EP1539964B1 (de)
JP (1) JP2005537807A (de)
CN (1) CN1694961A (de)
AT (1) ATE349538T1 (de)
AU (1) AU2003260286A1 (de)
DE (1) DE60310736T2 (de)
DK (1) DK1539964T3 (de)
ES (1) ES2279981T3 (de)
PT (1) PT1539964E (de)
WO (1) WO2004024925A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0522113D0 (en) * 2005-10-28 2005-12-07 Ares Trading Sa vWFA-domain containing proteins
EP2484691B1 (de) 2007-07-10 2016-01-13 Apogenix GmbH TNF-Superfamilie-Collectinfusionsproteine
EP2225269A2 (de) * 2007-11-09 2010-09-08 Anaphore, Inc. Fusionsproteine von mannosebindenden lektinen zur behandlung von krankheiten
US20100331240A1 (en) * 2008-01-18 2010-12-30 The General Hospital Corporation Methods for prevention and treatment of infections with supraphysiological doses of mannan-binding lectin (mbl) and ficolin-mbl fusion proteins
AU2009331327B2 (en) * 2008-12-22 2014-04-24 Fuso Pharmaceutical Industries, Ltd. Protein substance having triple helix structure and manufacturing method therefor
WO2010078966A1 (en) * 2009-01-09 2010-07-15 Apogenix Gmbh Fusion proteins forming trimers
US8993343B2 (en) * 2009-01-28 2015-03-31 Korea Research Institute Of Bioscience And Biotechnology CD93 or use of soluble fragment thereof
CA2767755C (en) * 2009-07-17 2021-10-12 Rigshospitalet Inhibitors of complement activation
SG10201503351RA (en) * 2010-01-19 2015-06-29 Harvard College Engineered Opsonin for Pathogen Detection and Treatment
KR20120135405A (ko) * 2010-03-04 2012-12-13 후소 야쿠힝 고교 가부시끼가이샤 허혈성 질환 항진 작용을 갖는 폴리펩티드
AU2011222883B2 (en) * 2010-03-05 2016-05-26 Omeros Corporation Chimeric inhibitor molecules of complement activation
CA3149018A1 (en) 2011-07-18 2013-01-24 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
CN104284984B (zh) 2012-02-29 2017-10-13 哈佛大学校长及研究员协会 抗生素药敏性的快速测试
US10551379B2 (en) 2013-03-15 2020-02-04 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
EP3848045A1 (de) 2013-05-21 2021-07-14 President and Fellows of Harvard College Manipulierte hämbindende zusammensetzungen und verwendungen davon
US10513546B2 (en) 2013-12-18 2019-12-24 President And Fellows Of Harvard College CRP capture/detection of gram positive bacteria
JP2014218510A (ja) * 2014-08-11 2014-11-20 アポゲニクスゲゼルシャフト ミット ベシュレンクテルハフツングＡｐｏｇｅｎｉｘ ＧｍｂＨ 三量体形成融合タンパク質
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof
JP2016210791A (ja) * 2016-08-03 2016-12-15 アポゲニクス アーゲー 三量体形成融合タンパク質
SG10201802979VA (en) * 2018-04-10 2019-11-28 Kah Meng Lim Immunological extract and method of production
WO2022079308A1 (en) * 2020-10-16 2022-04-21 Institut Pasteur Chimeric constructs useful in vaccination and cancer therapy
CN113307857B (zh) * 2021-01-14 2022-11-01 艾时斌 从表皮生长因子、凝集素和Tat蛋白衍生的支架蛋白
AU2022361048B2 (en) * 2021-10-07 2026-04-02 Omeros Corporation Targeted catalytic complement-activating molecules and methods of use thereof
CN114344453A (zh) * 2022-01-18 2022-04-15 华南师范大学 一种罗非鱼cl-k1在制备预防和/或治疗罗非鱼病害的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69836428T2 (de) * 1997-08-21 2007-09-27 Takara Bio Inc., Otsu Karzinostatische wirkstoffe
US7049099B2 (en) * 1998-01-23 2006-05-23 Fuso Pharmaceutical Industries, Ltd. Recombinant human mannan-binding proteins and producing method of the same
JPH11206378A (ja) * 1998-01-23 1999-08-03 Fuso Pharmaceutical Industries Ltd 組換えヒトマンナン結合タンパク質およびその製造方法
US6337193B1 (en) * 1998-11-24 2002-01-08 Aptagen, Inc. Expression of manose-binding protein in methylotrophic yeast
WO2000069894A2 (en) * 1999-05-14 2000-11-23 Steffen Thiel Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
RU2002113381A (ru) * 1999-12-02 2004-01-27 Дженс Христиан ДЖЕНСЕНИУС (DK) MASP-3, комплемент-связывающий фермент и его применение
JP5226169B2 (ja) * 2000-07-13 2013-07-03 ヘリオン バイオテック アンパーツゼルスカブ Ｍａｓｐ−２、すなわち補体固定酵素及びその使用
US20050137126A1 (en) * 2003-04-09 2005-06-23 Natlmmune A/S Treatment of SARS in individuals

Also Published As

Publication number Publication date
US20060188963A1 (en) 2006-08-24
ES2279981T3 (es) 2007-09-01
DE60310736T2 (de) 2007-10-11
WO2004024925A8 (en) 2004-05-21
JP2005537807A (ja) 2005-12-15
AU2003260286A1 (en) 2004-04-30
WO2004024925A3 (en) 2004-06-24
PT1539964E (pt) 2007-04-30
WO2004024925A2 (en) 2004-03-25
ATE349538T1 (de) 2007-01-15
CN1694961A (zh) 2005-11-09
DE60310736D1 (de) 2007-02-08
EP1539964B1 (de) 2006-12-27
EP1539964A2 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
ATE349538T1 (de) Collectin-komplement aktivierende proteinchimären
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
HRP20010877B1 (hr) Pripravci za prevenciju i liječenje amiloidogenskih bolesti
DE69412243D1 (de) Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
DE602004011770D1 (de) Fusionsproteine
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
KR950702248A (ko) 단백질을 기초로 한 전달 시스템(protein based delivery system)
CY1106152T1 (el) Νεα ανοσογονα αντι-hiv (ανατοξινες), μεθοδοι παρασκευης και εφαρμογη στην προληψη και στην αγωγη του aids
CY1118991T1 (el) Φαρμακοτεχνικη μορφη ανθρωπινων αντισωματων για θεραπεια σχετικων με tnf-αλφα διαταραχων
BR0313239A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de doenças
WO2001091773A3 (en) Method of stimulating hair growth
MXPA05008704A (es) Proteinas de fusion de muteinas de interferon alfa con propiedades mejoradas.
DE69133068D1 (de) Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
ATE427320T1 (de) Behandlung von infektionen verursacht von mikroorganismen
DE50113010D1 (de) Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE69131355D1 (de) Die knochenresorption hemmende verbindungen und zusammensetzungen
ATE368687T1 (de) Thrombopoietinproteine mit verbesserten eigenschaften
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
NO945031L (no) Anvendelse av en hymenopteragift til fremstilling av et medikament for behandling av DNA-virusinfeksjoner
DE60129606D1 (de) Mittel und verfahren zur vorbeugung von durch chemotherapie ausgelöster alopezie
ATE338770T1 (de) Mit bh4 fusionierte polypeptide